Drug
Tirbanibulin
Tirbanibulin is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_4
2
40%
Ph phase_2
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 42 (50.0%)
Trials by Status
completed360%
withdrawn120%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
completedphase_3
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
NCT06135415
completed
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073
withdrawnphase_4
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands
NCT06026358
recruitingphase_2
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
NCT06112522
completedphase_4
Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face
NCT05900258
Clinical Trials (5)
Showing 5 of 5 trials
NCT06135415Phase 3
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
NCT05260073
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT06026358Phase 4
Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands
NCT06112522Phase 2
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
NCT05900258Phase 4
Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5